Chemical industry – Page 49
-
BusinessUS court denies Amgen appeal over Pfizer biosimilar
Amgen has lost its bid to compel Pfizer to divulge information about its version of anaemia drug Epogen
-
BusinessChemical companies urged to update cyber defences
Outdated technology is leaving chemical, energy and petrochemical facilities vulnerable to ransomware attacks
-
BusinessRoche offloads majority of rights to lebrikizumab
Deal with Dermira could be worth well over $1 billion
-
BusinessCarbon capture from air goes commercial
Companies hope to produce pure carbon dioxide straight from the atmosphere
-
BusinessBristol-Myers Squibb bags immunotherapy unicorn
Deal will add to pharma giant’s cancer portfolio
-
BusinessGSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
-
BusinessGenesis Energy to buy alkali business from Tronox
Tronox to spend proceeds on Cristal purchase
-
BusinessIsraeli company Haifa Chemicals shuttered
Lack of ammonia storage facility leads to colossal losses
-
BusinessCelgene pays $280m to settle off-label marketing lawsuit
Whistleblower case relating to cancer prescriptions
-
BusinessMidwest Fertilizer to build $2.8bn manufacturing plant
Domestic facility will reduce imports
-
BusinessAstraZeneca shares tumble after antibody failure
Imfinzi and tremelimumab checkpoint inhibitor pairing fails to beat chemotherapy in lung cancer
-
BusinessLyondellBasell to build world’s largest propylene oxide plant
Petrochemical giant gets go-ahead for most expensive project to date
-
BusinessNovartis coasts towards first CAR-T approval
Unanimous recommendation for CTL019 ahead of October decision builds confidence in T-cell genetic reprogramming
-
BusinessMitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
-
NewsTrump and Dow Chemical chief executive clashed on climate
White House adviser and head of US’s largest chemical firm, Andrew Liveris, tried to change the president’s mind on Paris accord
-
Opinion(+)-Pleuromutilin
Total synthesis is sometimes the only way to explore the chemical space around a natural product
-
BusinessConsortium working to extend sustainable coconut oil supply chain
Agricultural education programme helps secure production and reduce environmental impact
-
BusinessBroad Institute backs central Crispr patent licensing platform
Key players submit 22 patents to pool, and urge other holders to create a one-stop shop for licensing deals
-
BusinessLilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
BusinessMallinckrodt settles US opioid lawsuit
Firm will pay $35m over allegations it failed to report suspicious orders of controlled substances